Dr. Lexing Li is a veterinary biomedical scientist whose work bridges fundamental immunology with practical applications in animal health. He completed his doctoral training in Basic Veterinary Medicine at Huazhong Agricultural University, where he developed strong expertise in macrophage biology, metabolic reprogramming, and autophagy regulation. His research explores how natural compounds—such as Houttuynia cordata and quercetin—modulate inflammation, oxidative stress, and cell-death pathways, contributing to the development of safe, antibiotic-free interventions in livestock production. Dr. Li has published extensively on the CXCL10-CXCR3 axis in tissue repair, the therapeutic potential of targeting FAK and LAMP1, and the role of lncRNAs in autophagy. His work has led to significant insights recognized through competitive research grants, including high-level talent start-up funds and national key laboratory open projects. Before joining academia as a lecturer, he gained five years of industry experience as a Technical Service Director and Product Manager, strengthening his ability to translate research findings into practical solutions for biomedicine and animal husbandry. His ongoing efforts aim to advance immunoregulation, natural-product pharmacology, and host–pathogen interactions, contributing to healthier livestock systems and innovative strategies for combating inflammatory diseases.